Date Title Description PDF
06 May 2026 On P&L The Company releases the press release related to the first three months of 2026 financial results. Download
06 May 2026 On P&L The Company releases the first three months of 2026 financial results presentation. Download
25 Feb 2026 On P&L The Company releases the press release related to the full year 2025 financial results. Download
25 Feb 2026 On P&L The Company releases the full year 2025 financial results presentation. Download
25 Feb 2026 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors. Download

Pages

5 / 63
Date Title Description PDF
15 Feb 2022 On business and financial situation ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. Download
14 Feb 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022 Download
07 Feb 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022 Download
31 Jan 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022 Download
24 Jan 2022 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022 Download

Pages

120 / 175
Date Title Description PDF
12 Jun 2013 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
06 Jun 2013 Otros sobre negocio y situación financiera Download
24 Apr 2013 Información sobre resultados (2) Download
24 Apr 2013 Información sobre resultados Download
24 Apr 2013 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download

Pages

165 / 194